Trial spotlights U.S. drug safety concerns at compounding pharmacies

Trial spotlights U.S. drug safety concerns at compounding pharmacies
A top U.S. Food and Drug Administration official testified on Monday that the agency has concerns about drugs made by compounding pharmacies and still sees problems with them six years after a fungal meningitis outbreak tied to a Massachusetts pharmacy killed 76 people.

Related posts